Top compounds associated with response to RARS


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA pac-1 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA KPT185 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA neratinib CTRPv2 pan-cancer AAC -0.12 0.001
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.12 0.001
mRNA alisertib CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV